Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 465

1.

Predictive Role of MRI and 18F FDG PET Response to Concurrent Chemoradiation in T2b Cervical Cancer on Clinical Outcome: A Retrospective Single Center Study.

Perrone AM, Dondi G, Coe M, Ferioli M, Telo S, Galuppi A, Crescenzo E, Tesei M, Castellucci P, Nanni C, Fanti S, Morganti AG, De Iaco P.

Cancers (Basel). 2020 Mar 12;12(3). pii: E659. doi: 10.3390/cancers12030659.

2.

A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G.

Oncologist. 2020 Feb;25(2):e311-e320. doi: 10.1634/theoncologist.2019-0309. Epub 2019 Oct 10.

3.

Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors.

Buwenge M, Scirocco E, Deodato F, Macchia G, Ntreta M, Bisello S, Siepe G, Cilla S, Alitto AR, Valentini V, Strigari L, Morganti AG, Cammelli S.

BMC Cancer. 2020 Feb 3;20(1):90. doi: 10.1186/s12885-020-6581-5.

4.

The VEGF gene polymorphism in glioblastoma may be a new prognostic marker of overall survival.

Djan I, Lucic S, Bjelan M, Vuckovic N, Vucinic N, Morganti AG, Djan M, Lucic M.

J BUON. 2019 Nov-Dec;24(6):2475-2482.

5.

Template-based automation of treatment planning in advanced radiotherapy: a comprehensive dosimetric and clinical evaluation.

Cilla S, Ianiro A, Romano C, Deodato F, Macchia G, Buwenge M, Dinapoli N, Boldrini L, Morganti AG, Valentini V.

Sci Rep. 2020 Jan 16;10(1):423. doi: 10.1038/s41598-019-56966-y.

6.

Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1).

Arcelli A, Guido A, Buwenge M, Simoni N, Mazzarotto R, Macchia G, Deodato F, Cilla S, Bonomo P, Scotti V, Belgioia L, Tolento G, Cellini F, Grassi E, DI Marco M, Casadei R, Morganti AG, Cammelli S.

Anticancer Res. 2020 Jan;40(1):465-472. doi: 10.21873/anticanres.13975.

PMID:
31892602
7.

The Role Of Effective Radiation Therapist-Patient Communication In Alleviating Treatment-Related Pain And Procedural Discomfort During Radiotherapy.

Mattarozzi K, Fino E, Panni V, Agostini A, Morganti AG, Russo PM.

Patient Prefer Adherence. 2019 Oct 30;13:1861-1865. doi: 10.2147/PPA.S214375. eCollection 2019.

8.

Radiotherapy Plus GnRH Analogue Versus High Dose Bicalutamide: A Case Control Study.

Buwenge M, Deodato F, Macchia G, Siepe G, Zhao X, Valicenti RK, Cilla S, Alitto AR, Ntreta M, Bisello S, Mantini G, Valentini V, Morganti AG, Cammelli S.

Anticancer Res. 2019 Nov;39(11):6373-6378. doi: 10.21873/anticanres.13850.

PMID:
31704870
9.

Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.

Cellini F, Manfrida S, Deodato F, Cilla S, Maranzano E, Pergolizzi S, Arcidiacono F, Di Franco R, Pastore F, Muto M, Borzillo V, Donati CM, Siepe G, Parisi S, Salatino A, D'Agostino A, Montesi G, Santacaterina A, Fusco V, Santarelli M, Gambacorta MA, Corvò R, Morganti AG, Masiello V, Muto P, Valentini V.

Trials. 2019 Oct 28;20(1):609. doi: 10.1186/s13063-019-3676-x.

10.

Short-Course 2-Dimensional Radiation Therapy in the Palliative Treatment of Esophageal Cancer in a Developing Country: A Phase II Study (Sharon Project).

Deressa BT, Tigeneh W, Bogale N, Buwenge M, Morganti AG, Farina E.

Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):67-72. doi: 10.1016/j.ijrobp.2019.10.004. Epub 2019 Oct 14.

PMID:
31622698
11.

A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.

Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D'Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M, Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G.

Oncologist. 2019 Oct 10. pii: theoncologist.2019-0309. doi: 10.1634/theoncologist.2019-0309. [Epub ahead of print]

12.

Anorectal adenocarcinoma recurrence successfully treated with electrochemotherapy: a case report.

Ferioli M, Guido A, Buwenge M, Coe M, Galuppi A, de Terlizzi F, Poggioli G, Morganti AG.

Anticancer Drugs. 2020 Jan;31(1):73-75. doi: 10.1097/CAD.0000000000000838.

PMID:
31567310
13.

Accelerated Middle Half Body Radiotherapy in Bone Metastases from Prostate Cancer: A Phase I Study (SHARON Project).

Zamagni A, Buwenge M, Macchia G, Siepe G, Cilla S, Cellini F, Arcelli A, Farina E, Deodato F, Cammelli S, Morganti AG.

Anticancer Res. 2019 Sep;39(9):5065-5069. doi: 10.21873/anticanres.13699.

PMID:
31519616
14.

Interventional radiotherapy (brachytherapy) for squamous cell carcinoma of the nasal vestibule: a multidisciplinary systematic review.

Tagliaferri L, Fionda B, Bussu F, Parrilla C, Lancellotta V, Deodato F, Cammelli S, Boldrini L, Gambacorta MA, Morganti AG, Valentini V, Paludetti G, Peris K, Kovacs G.

Eur J Dermatol. 2019 Aug 1;29(4):417-421. doi: 10.1684/ejd.2019.3599.

PMID:
31486400
15.

Palliative Short-course Radiotherapy in Advanced Pelvic Cancer: A Phase II Study (SHARON Project).

Farina E, Macchia G, Siepe G, Zamagni A, Buwenge M, Scirocco E, Cellini F, Deressa BT, Tigeneh W, Uddin KAFM, Sumon MA, Caravatta L, Genovesi D, Mauro FA, Cammelli S, Cilla S, Morganti AG, Deodato F.

Anticancer Res. 2019 Aug;39(8):4237-4242. doi: 10.21873/anticanres.13585.

PMID:
31366511
16.

Importance of the correct assessment of bone fractures in the clinical management of metastatic castration-resistant prostate cancer treated with radium-223: A case report.

Rizzini EL, Ghedini P, Cardano R, Bellarosa C, Morganti AG, Fanti S, Monari F.

Mol Clin Oncol. 2019 Jul;11(1):63-66. doi: 10.3892/mco.2019.1852. Epub 2019 May 6.

17.

Definition of fields margins for the optimized 2D radiotherapy of prostate carcinoma.

Buwenge M, Perrone M, Siepe G, Capocaccia I, Woldemariam AA, Wondemagegnhu T, Uddin KAFM, Sumon MA, Galofaro E, Macchia G, Deodato F, Cilla S, Morganti AG.

Mol Clin Oncol. 2019 Jul;11(1):37-42. doi: 10.3892/mco.2019.1855. Epub 2019 May 8.

18.

Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival.

Morganti AG, Cellini F, Buwenge M, Arcelli A, Alfieri S, Calvo FA, Casadei R, Cilla S, Deodato F, Di Gioia G, Di Marco M, Fuccio L, Bertini F, Guido A, Herman JM, Macchia G, Maidment BW 3rd, Miller RC, Minni F, Passoni P, Valentini C, Re A, Regine WF, Reni M, Falconi M, Valentini V, Mattiucci GC.

BMC Cancer. 2019 Jun 11;19(1):569. doi: 10.1186/s12885-019-5790-2.

19.

Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.

Bisello S, Buwenge M, Palloni A, Autorino R, Cellini F, Macchia G, Deodato F, Cilla S, Brandi G, Tagliaferri L, Cammelli S, Valentini V, Morganti AG, Mattiucci GC.

Anticancer Res. 2019 Jun;39(6):3095-3100. doi: 10.21873/anticanres.13445.

PMID:
31177154
20.

Palliative Electrochemotherapy in Vulvar Carcinoma: Preliminary Results of the ELECHTRA (Electrochemotherapy Vulvar Cancer) Multicenter Study.

Perrone AM, Galuppi A, Pirovano C, Borghese G, Covarelli P, De Terlizzi F, Ferioli M, Cara S, Morganti AG, De Iaco P.

Cancers (Basel). 2019 May 12;11(5). pii: E657. doi: 10.3390/cancers11050657.

21.

The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer.

Valentini V, Gambacorta MA, Cellini F, Aristei C, Coco C, Barbaro B, Alfieri S, D'Ugo D, Persiani R, Deodato F, Crucitti A, Lupattelli M, Mantello G, Navarria F, Belluco C, Buonadonna A, Boso C, Lonardi S, Caravatta L, Barba MC, Vecchio FM, Maranzano E, Genovesi D, Doglietto GB, Morganti AG, La Torre G, Pucciarelli S, De Paoli A.

Radiother Oncol. 2019 May;134:110-118. doi: 10.1016/j.radonc.2018.11.023. Epub 2019 Feb 7.

PMID:
31005204
22.

Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases.

Dionisi V, Bellarosa C, Cardano R, Rizzini EL, Ghedini P, Morganti AG, Fanti S, Monari F.

Clin Genitourin Cancer. 2019 Jun;17(3):e612-e617. doi: 10.1016/j.clgc.2019.03.002. Epub 2019 Mar 13. No abstract available.

23.

Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.

Ciabatti S, Ntreta M, Buwenge M, Gaudiano C, Sessagesimi E, Romani F, Angelini AL, Cammelli S, Macchia G, Deodato F, Zamagni A, Golfieri R, Morganti AG, Cilla S.

Med Dosim. 2019 Winter;44(4):356-364. doi: 10.1016/j.meddos.2019.01.008. Epub 2019 Apr 5.

PMID:
30955990
24.

Current state of interventional radiotherapy (brachytherapy) education in Italy: results of the INTERACTS survey.

Tagliaferri L, Kovács G, Aristei C, De Sanctis V, Barbera F, Morganti AG, Casà C, Pieters BR, Russi E, Livi L, Corvò R, Giovagnoni A, Ricardi U, Valentini V, Magrini SM; Directors of the Italian Radiation Oncology Schools.

J Contemp Brachytherapy. 2019 Feb;11(1):48-53. doi: 10.5114/jcb.2019.83137. Epub 2019 Feb 28. Review.

25.

Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis.

Arcelli A, Buwenge M, Macchia G, Cammelli S, Deodato F, Cilla S, Galuppi A, Panni V, Mattiucci GC, Tagliaferri L, Morganti AG.

J Contemp Brachytherapy. 2019 Feb;11(1):21-27. doi: 10.5114/jcb.2019.82804. Epub 2019 Feb 28.

26.

Epid-based in vivo dose verification for lung stereotactic treatments delivered with multiple breath-hold segmented volumetric modulated arc therapy.

Cilla S, Ianiro A, Craus M, Viola P, Deodato F, Macchia G, Buwenge M, Morganti AG, Valentini V, Piermattei A.

J Appl Clin Med Phys. 2019 Mar;20(3):37-44. doi: 10.1002/acm2.12538. Epub 2019 Feb 20.

27.

An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer.

Bisello S, Renzulli M, Buwenge M, Calculli L, Sallustio G, Macchia G, Deodato F, Mattiucci G, Cammelli S, Arcelli A, Giaccherini L, Cellini F, Brandi G, Guerri S, Cilla S, Golfieri R, Fuccio L, Morganti AG, Guido A.

Oncol Lett. 2019 Feb;17(2):1784-1790. doi: 10.3892/ol.2018.9774. Epub 2018 Nov 28.

28.

Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review.

Frakulli R, Buwenge M, Macchia G, Cammelli S, Deodato F, Cilla S, Cellini F, Mattiucci GC, Bisello S, Brandi G, Parisi S, Morganti AG.

Br J Radiol. 2019 May;92(1097):20180688. doi: 10.1259/bjr.20180688. Epub 2019 Feb 7.

PMID:
30673295
29.

Hibernation and Radioprotection: Gene Expression in the Liver and Testicle of Rats Irradiated under Synthetic Torpor.

Tinganelli W, Hitrec T, Romani F, Simoniello P, Squarcio F, Stanzani A, Piscitiello E, Marchesano V, Luppi M, Sioli M, Helm A, Compagnone G, Morganti AG, Amici R, Negrini M, Zoccoli A, Durante M, Cerri M.

Int J Mol Sci. 2019 Jan 16;20(2). pii: E352. doi: 10.3390/ijms20020352.

30.

First International Consensus on the diagnosis and management of fibromuscular dysplasia.

Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, Bruno RM, de Leeuw P, Fendrikova-Mahlay N, Froehlich J, Ganesh SK, Gray BH, Jamison C, Januszewicz A, Jeunemaitre X, Kadian-Dodov D, Kim ES, Kovacic JC, Mace P, Morganti A, Sharma A, Southerland AM, Touzé E, van der Niepen P, Wang J, Weinberg I, Wilson S, Olin JW, Plouin PF.

Vasc Med. 2019 Apr;24(2):164-189. doi: 10.1177/1358863X18821816. Epub 2019 Jan 16. Review. Erratum in: Vasc Med. 2019 Oct;24(5):475.

PMID:
30648921
31.

First international consensus on the diagnosis and management of fibromuscular dysplasia.

Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, Bruno RM, De Leeuw P, Fendrikova-Mahlay N, Froehlich J, Ganesh SK, Gray BH, Jamison C, Januszewicz A, Jeunemaitre X, Kadian-Dodov D, Kim ESH, Kovacic JC, Mace P, Morganti A, Sharma A, Southerland AM, Touzé E, Van der Niepen P, Wang J, Weinberg I, Wilson S, Olin JW, Plouin PF; Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH) and the Society for Vascular Medicine (SVM).

J Hypertens. 2019 Feb;37(2):229-252. doi: 10.1097/HJH.0000000000002019. Erratum in: J Hypertens. 2019 May;37(5):1098.

PMID:
30640867
32.

Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a multi-institutional contouring study on behalf of the AIRO group for gastrointestinal cancers.

Caravatta L, Cellini F, Simoni N, Rosa C, Niespolo RM, Lupattelli M, Picardi V, Macchia G, Sainato A, Mantello G, Dionisi F, Rosetto ME, Fusco V, Navarria F, De Paoli A, Guido A, Vecchi C, Basilico R, Cianci R, Delli Pizzi A, Di Nicola M, Mattiucci GC, Valentini V, Morganti AG, Genovesi D.

Acta Oncol. 2019 Apr;58(4):439-447. doi: 10.1080/0284186X.2018.1546899. Epub 2019 Jan 11.

PMID:
30632876
33.

Radiomics: the facts and the challenges of image analysis.

Rizzo S, Botta F, Raimondi S, Origgi D, Fanciullo C, Morganti AG, Bellomi M.

Eur Radiol Exp. 2018 Nov 14;2(1):36. doi: 10.1186/s41747-018-0068-z. Review.

34.

Feasibility of 2D-conformal radiotherapy for pancreatic carcinoma.

Buwenge M, Cilla S, Cammelli S, Macchia G, Arcelli A, Farina E, Frakulli R, Panni V, Wondemagegnhu T, Uddin AFMK, Sumon MA, Deodato F, Morganti AG.

Oncol Lett. 2018 Nov;16(5):5939-5945. doi: 10.3892/ol.2018.9389. Epub 2018 Sep 4.

35.

Dose escalation in extracranial stereotactic ablative radiotherapy (DESTROY-1): A multiarm Phase I trial.

Deodato F, Macchia G, Cilla S, Ianiro A, Sallustio G, Cammelli S, Buwenge M, Mattiucci GC, Valentini V, Morganti AG.

Br J Radiol. 2019 Feb;92(1094):20180422. doi: 10.1259/bjr.20180422. Epub 2018 Nov 1.

36.

Hypofractionated radiotherapy after conservative surgery may increase low-intermediate grade late fibrosis in breast cancer patients.

Digesù C, Deodato F, Macchia G, Cilla S, Pieri M, Zamagni A, Farioli A, Buwenge M, Ferrandina G, Morganti AG.

Breast Cancer (Dove Med Press). 2018 Oct 3;10:143-151. doi: 10.2147/BCTT.S167914. eCollection 2018.

37.

Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief.

Buwenge M, Macchia G, Arcelli A, Frakulli R, Fuccio L, Guerri S, Grassi E, Cammelli S, Cellini F, Morganti AG.

J Pain Res. 2018 Oct 4;11:2169-2178. doi: 10.2147/JPR.S167994. eCollection 2018. Review.

38.

Radiotherapy in palliation of thoracic tumors: a phase I-II study (SHARON project).

Farina E, Macchia G, Buwenge M, Siepe G, Zamagni A, Cammelli S, Cilla S, Wondemagegnhu T, Woldemariam AA, Uddin AFMK, Sumon MA, Cellini F, Deodato F, Morganti AG.

Clin Exp Metastasis. 2018 Dec;35(8):739-746. doi: 10.1007/s10585-018-9942-6. Epub 2018 Oct 8.

PMID:
30298381
39.

Radiotherapy of pancreatic cancer in older patients: A systematic review.

Ciabatti S, Cammelli S, Frakulli R, Arcelli A, Macchia G, Deodato F, Cilla S, Giaccherini L, Buwenge M, Morganti AG.

J Geriatr Oncol. 2019 Jul;10(4):534-539. doi: 10.1016/j.jgo.2018.09.007. Epub 2018 Sep 28. Review.

PMID:
30270196
40.

Efficacy and safety of 3D-conformal half body irradiation in patients with multiple bone metastases.

Macchia G, Ferro M, Cilla S, Buwenge M, Ianiro A, Boccardi M, Picardi V, Ferro M, Arena E, Zamagni A, Cammelli S, Valentini V, Morganti AG, Deodato F.

Clin Exp Metastasis. 2018 Dec;35(8):747-752. doi: 10.1007/s10585-018-9939-1. Epub 2018 Sep 24.

PMID:
30251079
41.

Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis.

Mattiucci GC, Morganti AG, Cellini F, Buwenge M, Casadei R, Farioli A, Alfieri S, Arcelli A, Bertini F, Calvo FA, Cammelli S, Fuccio L, Giaccherini L, Guido A, Herman JM, Macchia G, Maidment BW 3rd, Miller RC, Minni F, Regine WF, Reni M, Partelli S, Falconi M, Valentini V.

Transl Oncol. 2019 Jan;12(1):1-7. doi: 10.1016/j.tranon.2018.08.017. Epub 2018 Sep 17.

42.

Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose-escalation feasibility study.

Cilla S, Deodato F, Ianiro A, Macchia G, Picardi V, Buwenge M, Cammelli S, Zamagni A, Valentini V, Morganti AG.

J Appl Clin Med Phys. 2018 Nov;19(6):35-43. doi: 10.1002/acm2.12427. Epub 2018 Sep 15.

43.

Whole Lung Irradiation in Patients with Osteosarcoma and Ewing Sarcoma.

Ronchi L, Buwenge M, Cortesi A, Ammendolia I, Frakulli R, Abate ME, Arcelli A, Donati CM, Macchia G, Morganti AG, Cammelli S.

Anticancer Res. 2018 Sep;38(9):4977-4985. doi: 10.21873/anticanres.12816. Review.

PMID:
30194141
44.

Definitive Radiotherapy in Invasive Vaginal Carcinoma: A Systematic Review.

Guerri S, Perrone AM, Buwenge M, Ferioli M, Macchia G, Tagliaferri L, Ferrandina G, Galuppi A, Andrulli AD, Frakulli R, Cammelli S, Arcelli A, De Iaco P, Morganti AG.

Oncologist. 2019 Jan;24(1):132-141. doi: 10.1634/theoncologist.2017-0546. Epub 2018 Aug 23.

45.

Short-course regimen of palliative radiotherapy in complicated bone metastases: a phase i-ii study (SHARON Project).

Capuccini J, Macchia G, Farina E, Buwenge M, Genovesi D, Caravatta L, Nguyen NP, Cammelli S, Cilla S, Wondemagegnhu T, Uddin AFMK, Aziz Sumon M, Cellini F, Valentini V, Deodato F, Morganti AG.

Clin Exp Metastasis. 2018 Oct;35(7):605-611. doi: 10.1007/s10585-018-9931-9. Epub 2018 Aug 18.

PMID:
30121938
46.

Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters.

Lima GM, Matti A, Vara G, Dondi G, Naselli N, De Crescenzo EM, Morganti AG, Perrone AM, De Iaco P, Nanni C, Fanti S.

Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2139-2146. doi: 10.1007/s00259-018-4077-1. Epub 2018 Aug 2.

47.

Brachytherapy boost after chemoradiation in anal cancer: a systematic review.

Frakulli R, Buwenge M, Cammelli S, Macchia G, Farina E, Arcelli A, Ferioli M, Fuccio L, Tagliaferri L, Galuppi A, Frezza GP, Morganti AG.

J Contemp Brachytherapy. 2018 Jun;10(3):246-253. doi: 10.5114/jcb.2018.76884. Epub 2018 Jun 29. Review.

48.

Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial.

Mantini G, Siepe G, Alitto AR, Buwenge M, Nguyen NP, Farioli A, Schiavina R, Catucci F, Deodato F, Fionda B, Frascino V, Macchia G, Ntreta M, Padula GDA, Arcelli A, Cammelli S, Rambaldi GZ, Cilla S, Valentini V, Morganti AG.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):564-572. doi: 10.1038/s41391-018-0064-7. Epub 2018 Jul 23.

49.

68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy.

Farolfi A, Ceci F, Castellucci P, Graziani T, Siepe G, Lambertini A, Schiavina R, Lodi F, Morganti AG, Fanti S.

Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):11-19. doi: 10.1007/s00259-018-4066-4. Epub 2018 Jun 15.

PMID:
29905907
50.

In Memoriam: Alberto Zanchetti (Parma July 27, 1926 - Milan March 24, 2018).

Mancia G, Magrini F, Morganti A, Stella A, Schwartz PJ, Cuspidi C, Giannattasio C, Grassi G, Parati G; all of Alberto Zanchetti’s students, Weber MA, Lackland D.

J Clin Hypertens (Greenwich). 2018 May;20(5):826-828. doi: 10.1111/jch.13315. No abstract available.

Supplemental Content

Loading ...
Support Center